Mind-Body Skills Training for Type 1 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how mindfulness skills can help teens with type 1 diabetes manage their condition more effectively. Participants will attend either regular diabetes education sessions or sessions that include mindfulness practices such as deep breathing and meditation. The researchers aim to determine if these mind-body techniques improve blood sugar control, treatment satisfaction, and overall mental wellness. Teens who have had type 1 diabetes for at least a year and struggle with stable blood sugar levels might be suitable for this study. As an unphased trial, this study provides a unique opportunity for teens to explore innovative methods to enhance their diabetes management and overall well-being.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that mind-body skills training is safe for adolescents with type 1 diabetes?
Research shows that mindfulness and mind-body skills are generally safe for people with diabetes. Studies have found that mindfulness activities, like deep breathing and meditation, improve mental well-being without major side effects. For instance, a review of mindfulness-based stress reduction found it well-tolerated and beneficial for health, particularly in reducing stress and depression.
Additionally, research on teenagers with type 1 diabetes has shown that these methods are easy to follow and maintain, indicating their safety and effectiveness.
No reports of serious safety issues have emerged from these studies, meaning no major concerns have arisen. While these practices have been around for a while, combining them with diabetes education is a new approach. This combination is expected to enhance diabetes management without adding risk.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential benefits of combining mind-body skills with traditional diabetes education for people with Type 1 diabetes. Unlike standard treatments that primarily focus on medication and blood sugar monitoring, this approach incorporates deep breathing, self-reflection, and meditation to help manage stress. The innovative aspect here is the emphasis on self-awareness and stress reduction, which could complement existing treatments by addressing the emotional and mental health aspects of living with diabetes. This holistic approach could help improve overall well-being and diabetes management.
What evidence suggests that this trial's treatments could be effective for type 1 diabetes?
Research has shown that mindfulness practices can aid people with type 1 diabetes. These practices improve blood sugar management, as reflected in hemoglobin A1c (HbA1c) tests. They also reduce stress and depression, common among those with diabetes. Techniques such as deep breathing and meditation have been linked to better management and well-being in young people with type 1 diabetes. In this trial, one group of participants will receive both mind-body skills training and diabetes education, while another group will receive diabetes education alone. Evidence from several studies suggests that incorporating these skills into diabetes education can lead to better health outcomes.12567
Who Is on the Research Team?
Tamara S. Hannon, MD
Principal Investigator
Riley Hospital for Children at Indiana University Health
Are You a Good Fit for This Trial?
This trial is for adolescents aged 15-17 with type 1 diabetes that's not well-controlled (A1c of at least 9.0%) and have been diagnosed for over a year. They need consent from a parent or guardian to participate, and must be able to attend all study visits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 10-12 weekly group sessions with diabetes education and mind-body skills training
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Diabetes education
- Mind-body skills
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Eli Lilly and Company
Industry Sponsor
Dr. Daniel Skovronsky
Eli Lilly and Company
Chief Medical Officer since 2018
MD from Harvard Medical School
David A. Ricks
Eli Lilly and Company
Chief Executive Officer since 2017
BSc from Purdue University, MBA from Indiana University